Exelixis FY2025 EPS Forecast Lowered by Leerink Partnrs
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Investment analysts at Leerink Partnrs lowered their FY2025 EPS estimates for Exelixis in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of $2.10 for the year, down from their prior forecast of […]
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Investment analysts at Leerink Partnrs lowered their FY2025 EPS estimates for Exelixis in a research note issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of $2.10 for the year, down from their prior forecast of […]
